PATENT CLAIM ANALYSIS

Application Number: 15777102
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "030000"]

Abstract:
The present invention relates to a combination of ivermectin and brimonidine for use in the treatment and/or the prevention of moderate to severe rosacea, preferably by topical administration of a 1% ivermectin cream and 0.33% brimonidine gel.

Claim (Index 4):
The combination according to  claim 2 , wherein ivermectin is present in an amount of between 0.001 and 10 percent by weight, relative to the total weight of the composition; and wherein brimonidine or salts thereof are present in an amount of between 0.01 and 20 percent by weight relative to the total weight of the composition.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 93.0
- Lexical Diversity: 1.28125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14903906', '14257567', '14209927', '14209958', '15699692']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7614181657238437
- 35 USC 102 Novelty (BERT): 0.4830546478249736
- Combined Prediction Score: 0.7335818139339567
- Mean Citation Score: 178.87027400000005
- Max Citation Score: 190.1291
- Similarity Product: 137.8840366694331

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test